ea0099ep15 | Adrenal and Cardiovascular Endocrinology | ECE2024
Deischinger Carola
, Slukova Dorota
, Harreiter Jurgen
, Nopp Stephan
, Just Ivica
, Krssak Martin
, Trattnig Siegfried
, Kosi-Trebotic Lana
, Kaufmann Ulrike
, Kautzky-Willer Alexandra
Background: The differences in cardiac parameters such as myocardial mass, left ventricular ejection fraction (LVEF), cardiac output, and brain natriuretic peptide (NT-proBNP) levels between cisgender men and women are well-established. However, no evidence exists regarding changes in myocardial mass or cardiac function parameters in transgender individuals undergoing gender-affirming hormone therapy (GAHT).Patients and method: A prospective study enroll...